| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/09/2004 | US20040248766 Selective inhibition of intracellular amyloid-beta neurotoxicity in human neurons |
| 12/09/2004 | US20040248325 forming a probe with a cleavable tag for use in an immunometric assay which includes reacting the target-binding compound with a cleavable linker, reducing agent, and a specific tagging molecule that upon dissociation may be analyzed using microarray-based detection |
| 12/09/2004 | US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators |
| 12/09/2004 | US20040248322 Diagnostic test for analytes in a sample |
| 12/09/2004 | US20040248321 Membrane protein for use in treatment and prevention of inflammatory, circulatory, cell proliferative, metabolic and immunological disorders |
| 12/09/2004 | US20040248318 Apparatus for microfluidic processing and reading of biochip arrays |
| 12/09/2004 | US20040248317 Glycopeptide identification and analysis |
| 12/09/2004 | US20040248316 Device for use in fluid assay |
| 12/09/2004 | US20040248314 Determining flow fraction of mixture in hydrocarbon reservoir and extracting flow fraction and fluid property information from downhole measurements of mixture density and absolute pressure; measuring oil, water, and gas flow rate in each producing zone of an oil well |
| 12/09/2004 | US20040248312 Sensor with integrated lancet |
| 12/09/2004 | US20040248311 Using absorption spectrochemical analysis to determine extent of copper contamination of silicon semiconductor |
| 12/09/2004 | US20040248310 Method for detection of bromine in urine using liquid chemistry, dry chemistry test pads, and lateral flow |
| 12/09/2004 | US20040248309 Using spectrum analysis to determine concentration of high density lipoproteins cholesterol in sample; diagnosing/prognosing cardiovascular disorders |
| 12/09/2004 | US20040248308 Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample |
| 12/09/2004 | US20040248307 Method and system for marking and determining the authenticity of liquid hydrocarbons |
| 12/09/2004 | US20040248306 Chip for use in determining water quality in innumerable settings; pollution control |
| 12/09/2004 | US20040248287 Apparatus for monitoring multiple bioassay arrays simultaneously using minimal sample volume; microarray analysis and biopolymer hybridization |
| 12/09/2004 | US20040248283 Toxicity monitor |
| 12/09/2004 | US20040248282 Molecular sensing apparatus (biosensors) comprising single macromolecule spanning two electrodes for use in monitoring biopolymer concentrations in fluids |
| 12/09/2004 | US20040248271 Using phenol oxidase activity as diagnostic indicator of bacterial infection; diagnosis and prevention of food poisoning |
| 12/09/2004 | US20040248253 Methods and compositions for polypeptide engineering |
| 12/09/2004 | US20040248252 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 12/09/2004 | US20040248251 Receptors and membrane associated proteins |
| 12/09/2004 | US20040248248 Isolated human transporters proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/09/2004 | US20040248247 Helix-loop-helix (BHLH) motif and a per-rrnt-sim homology domain (pas domain) (BHLH-PAS) protein for use in identifying modulators for diagnosis, prevention and treatment of retardation and nervous system disorders |
| 12/09/2004 | US20040248243 Lipid metabolizing polypeptide for use in identifying modulators for treatment and prevention of cancer, nervous system, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 12/09/2004 | US20040248240 Nucleotide sequences coding membrane protein for use in identifying modulator for treatment of pain management, epilepsy, stroke, ischemia and heart disease |
| 12/09/2004 | US20040248237 Process and apparatus for preparing and presenting a tissue sample for histological study |
| 12/09/2004 | US20040248236 Bacillus strain and antibiotic screening method |
| 12/09/2004 | US20040248234 Sensitive and selective in vitro assay for the detection of reactive drug intermediates |
| 12/09/2004 | US20040248233 Using propyl hydroxylase expression system to identify modulators which interfere with or prevent generation of hypoxic states; screening modulator for treatment and prevention of cell proliferative and thrombotic disorder |
| 12/09/2004 | US20040248232 Method for treating Alzheimer's dementia |
| 12/09/2004 | US20040248229 Methods and kits for transferases |
| 12/09/2004 | US20040248226 Method of pre-treating sample for measuring saccharified amine and method of measuring saccharified amine |
| 12/09/2004 | US20040248225 Luciferin hydrazides |
| 12/09/2004 | US20040248224 Detection of antibodies to squalene in serum |
| 12/09/2004 | US20040248222 Monoclonal antibodies specific for buprenorphine and metabolites thereof |
| 12/09/2004 | US20040248221 Using transgenic tumor cells as models for antitumor agent efficacy; tissue targeted therapy and antiproliferative agents |
| 12/09/2004 | US20040248220 Using cadherin expression as diagnostic and prognostic indicator of tumor cell expression and/or progression |
| 12/09/2004 | US20040248219 Methods for diagnosing and evaluating cancer |
| 12/09/2004 | US20040248218 Gene SCC-112 and diagnostic and therapeutic uses thereof |
| 12/09/2004 | US20040248217 Using presence of calreticulin in urine as diagnostic indicator of urogenital cell proliferative disorders; immunoassay |
| 12/09/2004 | US20040248216 Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor |
| 12/09/2004 | US20040248214 Monitoring natural killer cell activity in humans; antitumor agents; immunotherapy |
| 12/09/2004 | US20040248213 Method and kit for cell analyte assay |
| 12/09/2004 | US20040248212 determine the specific sequence of that portion of peptides or proteins that bind to a receptor or target of interest, or mediate a biological activity of interest; forming a metallopeptides with serially substituted sequences and screening for altered binding activity; metallopeptide libraries |
| 12/09/2004 | US20040248211 Hybridoma cell line comprising intracellular adhesion molecules for use in generating immunoglobulins to treatment autoimmune, skin and inflammatory disorders |
| 12/09/2004 | US20040248210 A molecule of the antigen binding portion phosphoryalated at residue Ser211 or Ser226 of a specific amino acid sequence; determining glucocorticoid receptors in cells from human glucocorticoid responsive tissue; agonist screening |
| 12/09/2004 | US20040248209 Identifying modulators which modify binding activity of isoprenoids and membrane protein receptors for use in treatment of diabetes, obesity, pain, inflamatory, cardiovascular, cancer and liver disorders |
| 12/09/2004 | US20040248208 Screening method |
| 12/09/2004 | US20040248207 Sodium channel regulators and modulators |
| 12/09/2004 | US20040248205 Major histocompatibility complex (MHC)-peptide arrays |
| 12/09/2004 | US20040248204 Using blood glucose concentrations to diagnose/prognose defects in glucose metabolism |
| 12/09/2004 | US20040248203 Bodipy fluorophore dyes useful in the labeling and identification of proteins |
| 12/09/2004 | US20040248202 Labeled chimeric membrane protein for use as tool in identifying modulators for treatment and prevention of viral infection and cell proliferative disorders |
| 12/09/2004 | US20040248200 Method of diagnosing cerebral infarction |
| 12/09/2004 | US20040248199 Method for determining the presence of bacteria resistant to cell lysing antibiotics |
| 12/09/2004 | US20040248198 Arf and hdm2 interaction domains and methods of use thereof |
| 12/09/2004 | US20040248197 Assay method for alzheimer's disease |
| 12/09/2004 | US20040248196 Methods of screening based on the egf receptor crystal structure |
| 12/09/2004 | US20040248195 Uses of a thyx polypeptide or a nucleic acid encoding such a polypeptide, in particular for screening anti-bacterial or anti-viral compounds |
| 12/09/2004 | US20040248194 Peptide screen |
| 12/09/2004 | US20040248193 Using presence of antibody specific for wheat gluten to diagnose coeliac disease; immunodiagnostics |
| 12/09/2004 | US20040248190 Compositions and kits for differential diagnosis of hydatidiform moles and methods of using the same |
| 12/09/2004 | US20040248189 Method of making a library of phylogenetically related sequences |
| 12/09/2004 | US20040248186 Nucleic acid sequencing by Raman monitoring of uptake of precursors during molecular replication |
| 12/09/2004 | US20040248185 Nucleic acid sequencing by raman monitoring of uptake of precursors during molecular replication |
| 12/09/2004 | US20040248182 Efficient methods for multibody simulations |
| 12/09/2004 | US20040248181 Method and kit for enhancing extraction and quantification of target molecules using microdialysis |
| 12/09/2004 | US20040248179 Cbg gene as a genetic marker of hypercortisolism and associated pathologies |
| 12/09/2004 | US20040248173 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 12/09/2004 | US20040248171 Using hypermethylation of regulatory protein gene sequences has diagnostic indicator of breast, lung and colon cancers |
| 12/09/2004 | US20040248167 Multicompartment apparatus for the rapid detection of DNA, proteins and viruses |
| 12/09/2004 | US20040248165 Nucleic acid immobilization method and manufacturing method of biosensor using same |
| 12/09/2004 | US20040248162 Releasable polymer arrays |
| 12/09/2004 | US20040248158 Using upregulated marker gene expression as treatment targets and diagnostic indicator for cell proliferative and autoimmune disorders |
| 12/09/2004 | US20040248155 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 12/09/2004 | US20040248152 Identifying herbicidal agents where the site of action is carbonic anhydrase; enzyme inhibitors and crop protection; weed control |
| 12/09/2004 | US20040248151 Method for predicting the response to HER2-directed therapy |
| 12/09/2004 | US20040248149 Nucleotide sequences coding G-protein coupled receptor (T2R) for use in identifying modulators which control bitterness; food processing and pharmocological design |
| 12/09/2004 | US20040248148 Ultrasensitive detection of pathogenic microbes |
| 12/09/2004 | US20040248142 Method for detecting hepatocellular carcinoma |
| 12/09/2004 | US20040248139 Eit-6, a polypeptide encoded by an estrogen regulated gene |
| 12/09/2004 | US20040248137 Human and mammalian stem cell-derived neuron survival polypeptides |
| 12/09/2004 | US20040248132 Regulatory sequences which control expression from seven in absentia homologue-1(siah-1) and death receptor 5 (DR5) for use in identifying modulators of apoptosis and cell proliferative; antitumor agents |
| 12/09/2004 | US20040248128 Using flow cytometry to monitor interaction between medical coating materials and biopolymers to be used in hemodialyzers, leukocyte-removing filters for transfusion and artificial blood vessels |
| 12/09/2004 | US20040248127 Using polyacrylamide electrophoresis to fractionate covalently modified soluble membrane proteins in solution |
| 12/09/2004 | US20040248126 Method of detecting toxic substance |
| 12/09/2004 | US20040248122 Comprises substrate presenting reflecting main surface with localized sites (containing halogen, silane, or silanol groups) which are sensitive to fluorescence detection by transparent layer; microarrays; improved fluorescence |
| 12/09/2004 | US20040248117 Using ion-conductive, polyacrylamide-based microtiter plate comprising immobilized biopolymer binding agents for use in screening and separation of pharmaceutical agents |
| 12/09/2004 | US20040248116 Using cancer marker gene expression patterns to diagnose, classify and prognosticate cell proliferative disorders |
| 12/09/2004 | US20040248115 Nucleotide sequence probes for detecting beer-spoilage lactic acid bacteria; food processing and alcoholic beverages |
| 12/09/2004 | US20040248111 Screening method using solid supports modified with self-assembled monolayers |
| 12/09/2004 | US20040248110 Random truncation and amplification of nucleic acid |
| 12/09/2004 | US20040248109 Methods for selecting protein binding moieties |
| 12/09/2004 | US20040248099 Calcium-activated potassium channels; 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives act as inhibitors; gene knockout; skin disorders; psoriasis; wound healing |
| 12/09/2004 | US20040248098 Using rearrangements in microsatellite sequences (numbers present) detected via variation in mass to charge ratio to identify genomic polymorphism |
| 12/09/2004 | US20040248097 Interleukin-20 variants and promoters |
| 12/09/2004 | US20040248081 Composition comprising latency-associated nuclear antigen (LANA) for use in identifying modulators which prevent viral association with genomic nucleotide sequences; treating viral infections and cell proliferative disorders; viricides |
| 12/09/2004 | US20040248079 Detecting presence of nucleoside diphosphate in a sample comprising monitoring dephosphorylation of phosphoenzyme form of nucleoside diphosphate kinase (NDPK); bioenergetics and metabolism |